Lucas Gazarini

Lucas Gazarini

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2012 in Neuropsychopharmacology
Verified
Journal Article
Closed access
CSCristina A J Stern
Cristina A J Stern
LGLucas Gazarini
Lucas Gazarini
RTReinaldo N Takahashi
Reinaldo N Takahashi
FGFrancisco S Guimarães
Francisco S Guimarães
LBLeandro J Bertoglio
Leandro J Bertoglio

15 March 2013 in Learning & Memory
Verified
Journal Article
Open access
PDF file
LGLucas Gazarini
Lucas Gazarini
CSCristina A. Jark Stern
Cristina A. Jark Stern
ACAntônio P. Carobrez
Antônio P. Carobrez
LBLeandro J. Bertoglio
Leandro J. Bertoglio
Consolidation and reconsolidation are phases of memory stabilization that diverge slightly. Noradrenaline is known to influence both processes, but the relative contribution of α1- and β-adrenoceptors is unclear. The present study sought to investigate this matter by comparing their recruitment to consolidate and/or reconsolidate a contextual fear memory trace under enhanced noradrenergic activity induced by yohimbine. We report that this α2-adrenoceptor antagonist was able to potentiate fear memory trace consolidation or reconsolidation when administered immediately after acquisition or retrieval, respectively, resulting in increased freezing expression. In either case, generalization of this response to an unpaired context was also seen when it achieved a ceiling level in the paired context. These effects endured for over 7 d and relied on action at central rather than peripheral sites, but were prevented when a memory trace was not acquired, when memory reactivation was omitted, or when administration of yohimbine was delayed until 6 h after acquiring or retrieving the memory trace. The β-adrenoceptor antagonist propranolol was able to prevent the above-mentioned effects of yohimbine, while pretreatment with the α1-adrenoceptor antagonist prazosin blocked only its facilitating effects on memory reconsolidation. These results highlight a differential participation of α1- and β-adrenoceptors in fear memory processing. Moreover, it was shown that the α2-adrenoceptor agonist clonidine, as opposed to yohimbine, mitigates fear expression by weakening memory consolidation or reconsolidation.

31 October 2014 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
LGLucas Gazarini
Lucas Gazarini
CSCristina A. J. Stern
Cristina A. J. Stern
RPRene R. Piornedo
Rene R. Piornedo
RTReinaldo N. Takahashi
Reinaldo N. Takahashi
LBLeandro J. Bertoglio
Leandro J. Bertoglio
Traumatic memories have been resilient to therapeutic approaches targeting their permanent attenuation. One of the potentially promising pharmacological strategies under investigation is the search for safe reconsolidation blockers. However, preclinical studies focusing on this matter have scarcely addressed abnormal aversive memories and related outcomes. By mimicking the enhanced noradrenergic activity reported after traumatic events in humans, here we sought to generate a suitable condition to establish whether some clinically approved drugs able to disrupt the reconsolidation of conditioned fear memories in rodents would still be effective. We report that the α2-adrenoceptor antagonist yohimbine was able to induce an inability to restrict behavioral (fear) and cardiovascular (increased systolic blood pressure) responses to the paired context when administered immediately after acquisition, but not 6h later, indicating the formation of a generalized fear memory, which endured for over 29 days and was less susceptible to suppression by extinction. It was also resistant to reconsolidation disruption by the α2-adrenoceptor agonist clonidine or cannabidiol, the major non-psychotomimetic component of Cannabis sativa. Since signaling at N-methyl-D-aspartate (NMDA) receptors is important for memory labilization and because a dysfunctional memory may be less labile than is necessary to trigger reconsolidation on its brief retrieval and reactivation, we then investigated and demonstrated that pre-retrieval administration of the partial NMDA agonist D-cycloserine allowed the disrupting effects of clonidine and cannabidiol on reconsolidation. These findings highlight the effectiveness of a dual-step pharmacological intervention to mitigate an aberrant and enduring aversive memory similar to that underlying the post-traumatic stress disorder.

1 June 2015 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
CSCristina A.J. Stern
Cristina A.J. Stern
LGLucas Gazarini
Lucas Gazarini
AVAna C. Vanvossen
Ana C. Vanvossen
AZAntonio W. Zuardi
Antonio W. Zuardi
IGIsmael Galve-Roperh
Ismael Galve-Roperh
LBLeandro J. Bertoglio
Leandro J. Bertoglio

1 September 2010 in Neuroscience
Verified
Journal Article
Closed access
CSC.A.J. Stern
C.A.J. Stern
FMF.H.M. Do Monte
F.H.M. Do Monte
LGLucas Gazarini
Lucas Gazarini
ACA.P. Carobrez
A.P. Carobrez
LBL.J. Bertoglio
L.J. Bertoglio

10 January 2014 in Learning & Memory
Verified
Journal Article
Open access
PDF file
CSCristina A.J. Stern
Cristina A.J. Stern
LGLucas Gazarini
Lucas Gazarini
AVAna C. Vanvossen
Ana C. Vanvossen
MHMayara S. Hames
Mayara S. Hames
LBLeandro J. Bertoglio
Leandro J. Bertoglio
The prelimbic cortex has been implicated in the consolidation of previously learned fear. Herein, we report that temporarily inactivating this medial prefrontal cortex subregion with the GABAA agonist muscimol (4.0 nmol in 0.2 μL per hemisphere) was able to equally disrupt 1-, 7-, and 21-d-old contextual fear memories after their brief retrieval in rats. In all cases, this effect was prevented when memory reactivation was omitted. These results indicate that recent and remote fear memories are susceptible to reconsolidation blockade induced by prelimbic cortex inactivation. It was also demonstrated that the disrupting effect of prelimbic cortex inactivation on fear memory persisted over 11 d, and did not show extinction-related features, such as reinstatement. Infusing the same dose and volume of muscimol bilaterally into the infralimbic cortex after brief retrieval/reactivation of the fear memory did not disrupt it, as seen in prelimbic cortex-inactivated animals. The expression of Zif268/Egr1, the product of an immediate early gene related to memory reconsolidation, was also less pronounced in the infralimbic cortex than in prelimbic cortex following memory retrieval/reactivation. Altogether, the present findings highlight that activity in the prelimbic cortex may reestablish reactivated aversive memories and, therefore, contribute to their maintenance over time.